Sensocure develops and manufactures biomedical sensors for healthcare, and aim to become the market leader in postoperative monitoring of internal organs.
Sensocure specialiszes in ischemia monitoring
The main product under development is IscAlert™, a CO2 sensor designed for the earliest possible detection of ischemia. Ischemia is a condition where the cells do not get enough oxygen to survive because of inadequate blood supply, and is the number 1 killer.
Early warning – Early action
If ischemia is detected early enough, the damage can be reversed and tissue saved. IscAlert™ detects ischemia at a very early stage by measuring the partial pressure of carbon dioxide in a body (a universal indicator of good blood supply).
Ischemia occurs in the form of myocardial infarction, stroke or
complications after operations and accidents, and is considered
the most common disease and cause of death in the
On January 1st 2017 Sensocure moved into its new facilities at Skoppum. The facility is in a new building of approximately 1000 square meters constituting a new wing of Langmyra 11. Here we can continue developing our product in a 300 square meters’ cleanroom class 6,...
17. Feb 2015: The Nano2021 program has allocated funding for six projects after the announcement of funds with deadline 15.10.2014. In total 54,8 million NOK was distributed. Sensocure was one of the six projects that reached up with a research project entitled...
27. Jan 2014: Sensocure is about to start the main project for calibration and user interface for IscAlert™, funded by Oslofjordfondet. In collaboration with Oslo University Hospital, Buskerud and Vestfold University College, MicroTech Innovation, Eker Design and...